| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/17/2011 | CA2808582A1 Imidamide sphingosine kinase inhibitors |
| 02/17/2011 | CA2771105A1 Compositions and methods for the therapy and diagnosis of influenza |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2769822A1 Methods of modulating immune function |
| 02/17/2011 | CA2768965A1 Use of il-15 to increase thymic output and to treat lymphopenia |
| 02/16/2011 | EP2284192A2 Camelidae antibodies for sublingual administration |
| 02/16/2011 | EP2284190A2 Transfer factor from birds eggs |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284172A1 Immunomodulating heterocyclic compounds |
| 02/16/2011 | EP2283898A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283860A2 Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/16/2011 | EP2283845A1 Sustained release drug delivery system containing codrugs |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283833A2 Amines and amides for the treatment of diseases |
| 02/16/2011 | EP2283040A2 Methods and compositions based on alk1 antagonists for modulating angiogenesis and pericyte coverage |
| 02/16/2011 | EP2283013A1 Inhibitors of phosphatidylinositol 3-kinase |
| 02/16/2011 | EP2282760A1 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 02/16/2011 | EP1835021B1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 02/16/2011 | CN101978066A Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 02/16/2011 | CN101977627A Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 02/16/2011 | CN101977603A Methods using immunomodulatory compounds for modulating level of cd59 |
| 02/16/2011 | CN101977602A Immunosuppressive macrolide powder for oral suspension |
| 02/16/2011 | CN101974483A Application of mesenchymal stem cell in sicca syndrome |
| 02/16/2011 | CN101974397A Healthcare wine and preparation method thereof |
| 02/16/2011 | CN101974395A Powerful antifatigue super oxide dismutase (SOD) health wine and preparation method thereof |
| 02/16/2011 | CN101974392A Preparation method of ginseng flower active liquor |
| 02/16/2011 | CN101974094A Method for comprehensively extracting cudrania tricuspidata polysaccharides and flavones |
| 02/16/2011 | CN101974073A Anti-inflammatory hexapeptide |
| 02/16/2011 | CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
| 02/16/2011 | CN101973957A 5-benzylidene-2,4-thiazolidinedione derivatives and preparation method and application thereof |
| 02/16/2011 | CN101973925A 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof |
| 02/16/2011 | CN101973898A 2-p-octylphenethyl-2-aminopropylene glycol derivative and application thereof |
| 02/16/2011 | CN101972483A RNAI-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions |
| 02/16/2011 | CN101972479A Preparation process of intravenous injection human immunoglobulin |
| 02/16/2011 | CN101972472A Method for purifying and preparing allergen vaccine |
| 02/16/2011 | CN101972471A Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof |
| 02/16/2011 | CN101972469A Immune preparation for aquatic animals |
| 02/16/2011 | CN101972449A Chinese medicinal material earthworm enzyme and peptide compound preparation and preparation method thereof |
| 02/16/2011 | CN101972388A Extraction method of smilax glabra total glycoside extractive |
| 02/16/2011 | CN101972358A Compound lucid ganoderma health-care tea |
| 02/16/2011 | CN101972351A Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura |
| 02/16/2011 | CN101972292A Method for measuring flavone glycoside compounds in herba epimedii |
| 02/16/2011 | CN101972290A Extraction process of scabrous doellingeria herb total saponin |
| 02/16/2011 | CN101972277A Preparation process of bee glue injection |
| 02/16/2011 | CN101972258A Immunologic suppression effect of hydroxycamptothecine and therapeutic effect of hydroxycamptothecine on rheumatoid arthritis |
| 02/16/2011 | CN101508739B Radio frequency auxiliary method for extracting glossy ganoderma seed polysaccharide |
| 02/16/2011 | CN101361881B Preparation method as protein medicine lysozyme intestinal-tract sorbefacient |
| 02/16/2011 | CN101234145B Chinese medicinal composition for relieving itching, preparation and application thereof |
| 02/15/2011 | US7888490 Site-directed mutagenesis of the native genes of the toxin proteins, Protective Antigen, Lethal Factor and Edema Factor, using polymerase chain reaction; expression and purification |
| 02/15/2011 | US7888460 a mutant gliadin protein with the mutation in the epitope 62PQPQLPY68, or a fragment of such mutant protein (non-glidin sequence), decreases the ability of the epitope to induce a Tcell or antibody response |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888388 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888071 DNA encoding IL-2 fusion proteins with modulated selectivity |
| 02/15/2011 | US7888056 Method of forming a peptide-receptor complex with zsig33 |
| 02/15/2011 | US7887823 Oat extracts: refining, compositions and methods of use |
| 02/15/2011 | US7887807 Anti-IL-12 antibodies and compositions |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 02/15/2011 | CA2624949C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 02/15/2011 | CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2383424C Novel b7-4 molecules and uses therefor |
| 02/15/2011 | CA2373554C Process for the preparation and purification of thiol-containing maytansinoids |
| 02/15/2011 | CA2354046C New cancer treatments |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/11/2011 | CA2721040A1 Procyanidin extracts of cinnamon, litchi and arachis useful in the treatment of retroviral infections |
| 02/10/2011 | WO2011016558A1 Method for producing glucosylceramide-containing material |
| 02/10/2011 | WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2011016432A1 Immune balance-regulating agent |
| 02/10/2011 | WO2011014925A1 Process for obtaining peptide fractions |
| 02/10/2011 | WO2010068810A3 Certain substituted amides, method of making, and method of use thereof |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110034564 Soluble complexes of curcumin |
| 02/10/2011 | US20110034558 DP2 Antagonist and Uses Thereof |
| 02/10/2011 | US20110034543 DNA Vaccination For Treatment of Multiple Sclerosis and Insulin-Dependent Diabetes Mellitus |
| 02/10/2011 | US20110034542 Novel synthetic analogs of sphingolipids |
| 02/10/2011 | US20110034541 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 02/10/2011 | US20110034537 Compositions and methods for inhibiting expression of cd45 gene |
| 02/10/2011 | US20110034532 Modulation of T Cell Signaling Threshold and T Cell Sensitivity to Antigens |
| 02/10/2011 | US20110034527 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/10/2011 | US20110034524 Hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor |
| 02/10/2011 | US20110034520 Inhibitors of P38 Map Kinase |
| 02/10/2011 | US20110034516 Aminopyrazole derivatives |
| 02/10/2011 | US20110034512 Indazole Compounds As CCR1 Receptor Antagonists |
| 02/10/2011 | US20110034509 Beta-2-Adrenoreceptor Agonists |
| 02/10/2011 | US20110034458 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 02/10/2011 | US20110034457 Pyridothiophene Compounds |